Oxicams (e.g. piroxicam, meloxicam) are widely used nonsteroidal anti-inflammatory drugs (NSAIDs). A large body of evidence from epidemiological and preclinical studies has shown that NSAIDs have a chemopreventive effect on different types of cancer, especially in colorectal cancer. Moreover, mounting evidence from preclinical and clinical studies suggests that persistent inflammation functions as a driving force in the journey to cancer. What is more, inflammation induces reactive oxygen and nitrogen species, which cause damage to important cellular components (e.g., DNA, proteins and lipids), which can directly or indirectly contribute to malignant cell transformation. In this study, we discuss the synthesis and the resultant newly synthesized oxicam derivatives which are potentially chemopreventive, and at the same time antioxidant. Compound 9c, with the highest therapeutic index in the LoVo cancer cell line, was found to be the most efficient in ROS scavenging activity under conditions of oxidative stress.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.18388/abp.2018_2614 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Synthesis, characterization, molecular docking and pharmacological evaluation of isoxazole derivatives as potent anti-inflammatory agents.
Heliyon
November 2024
Drug Design Laboratory, School of Pharmaceutical Sciences, IFTM University, 244102, Moradabad, India.
Article Synopsis
- The study focuses on the synthesis and anti-inflammatory effects of thirteen new substituted-isoxazole derivatives (5a-5m), which are important compounds in medicinal chemistry.
- The main goals were to create these new compounds, evaluate how they interact with COX-1/2 enzymes using computational methods, and test their anti-inflammatory effects in lab animals.
- Results show that three of the compounds exhibited significant anti-inflammatory properties and low toxicity, suggesting potential for further medicinal use.
Indomethacin inhibits human seasonal coronaviruses at late stages of viral replication in lung cells: Impact on virus-induced COX-2 expression.
J Virus Erad
September 2024
Department of Biology, University of Rome Tor Vergata, Rome, Italy.
Coronaviruses (CoV), zoonotic viruses periodically emerging worldwide, represent a constant potential threat to humans. To date, seven human coronaviruses (HCoV) have been identified: HCoV-229E, HCoV-NL63, HCoV-OC43 and HCoV-HKU1, globally circulating in the human population (seasonal coronaviruses, sHCoV), and three highly-pathogenic coronaviruses, SARS-CoV, MERS-CoV and SARS-CoV-2. Although sHCoV generally cause only mild respiratory diseases, severe complications may occur in specific populations, highlighting the need for broad-spectrum anti-coronavirus drugs.
View Article and Find Full Text PDFUncovering therapeutic targets for macrophage-mediated T cell suppression and PD-L1 therapy sensitization.
Cell Rep Med
September 2024
Department of Cell, Developmental & Cancer Biology, Oregon Health & Science University, Portland, OR, USA; Center for Experimental Therapeutics, Oregon Health & Science University, Portland, OR, USA; Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA. Electronic address:
Tumor-associated macrophages (TAMs) and other myelomonocytic cells are implicated in regulating responsiveness to immunotherapies, including immune checkpoint inhibitors (ICIs) targeting the PD-1/PD-L1 axis. We have developed an ex vivo high-throughput approach to discover modulators of macrophage-mediated T cell suppression, which can improve clinical outcomes of ICIs. We screened 1,430 Food and Drug Administration (FDA)-approved small-molecule drugs using a co-culture assay employing bone-marrow-derived macrophages (BMDMs) and splenic-derived T cells.
View Article and Find Full Text PDFNeuroprotective effect of omidenepag on excitotoxic retinal ganglion cell death regulating COX-2-EP2-cAMP-PKA/Epac pathway via Neuron-Glia interaction.
Neuroscience
August 2024
Department of Ophthalmology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Article Synopsis
- Glutamate excitotoxicity contributes to the death of retinal ganglion cells (RGCs) in conditions like glaucoma and ischemia-reperfusion injury, causing both direct and indirect damage through inflammation.
- The study focused on Omidenepag (OMD), a new drug that lowers intraocular pressure and acts as an EP2 receptor agonist, investigating its potential neuroprotective effects against excitotoxic RGC death.
- OMD was found to significantly reduce RGC death and inflammatory responses in both in vitro and in vivo models, suggesting it promotes protective pathways while inhibiting harmful ones by improving interactions between glial cells and neurons.
Design, synthesis and anti-inflammatory assessment of certain substituted 1,2,4-triazoles bearing tetrahydroisoquinoline scaffold as COX 1/2-inhibitors.
Bioorg Chem
September 2024
Medicinal and Pharmaceutical Chemistry Department, Pharmaceutical and Drug Industries Research Institute, National Research Centre (ID: 60014618), P.O. 12622, Dokki, Giza, Egypt. Electronic address:
Aiming to discover effective and safe non-steroidal anti-inflammatory agents, a new set of 1,2,4-triazole tetrahydroisoquinoline hybrids 9a-g, 11a-g and 12a-g was synthesized and evaluated as inhibitors of COX-1 and COX-2. In order to overcome the adverse effects of highly selective COX-2 and non-selective COX-2 inhibitors, the compounds of this study were designed with the goal of obtaining moderately selective COX-2 inhibitors. In this study compounds 9e, 9g and 11f are the most effective derivatives against COX-2 with IC values 0.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!